Commentary

SSRIs in pediatric patients


 

“SSRIs in children and adolescents: Where do we stand?” (Current Psychiatry, March 2004) is excellent and timely.

As a child psychiatrist working in inpatient and outpatient settings, I have often seen activation and dysphoria in depressed children taking selective serotonin reuptake inhibitors (SSRIs). Drs. A. Bela Sood, Elizabeth Weller, and Ronald Weller reflect my view that “bipolar illness may be a possible explanation.” Without a high index of suspicion for bipolarity and a thorough family history, physicians are likely to be surprised when suicidality emerges after starting an antidepressant.

SSRIs clearly have contributed to the wellbeing of children with mood and anxiety disorders and are safe and effective in clinical practice. Unfortunately, the article does not address the dangers of using SSRIs in youths with bipolar disorder.

Stephen J. Wieder MD
Newburyport, MA

The authors respond

Dr. Wieder raises a pertinent clinical question regarding use of SSRIs in children at risk for bipolar disorder. SSRIs could cause hypomania or mania in depressed children with a clear history of bipolar disorder. When the clinical picture is not as clear, however, keep the following data in mind.

Follow-up studies have shown that 20% to 40% of adolescents with major depression develop bipolar type I disorder within 5 years after onset of depression.1 The clinician must strongly consider using prophylactic mood stabilizers along with SSRIs in depressed adolescents who present with psychomotor retardation, psychosis, family history of bipolar illness, and previous hypomanic disinhibition secondary to SSRI use, as these predict future bipolar disorder.2,3 Baseline irritability and aggression should also contraindicate SSRI monotherapy in unipolar depression, as exacerbation of rage and impulsivity with SSRIs seems to be high in this population.

A. Bela Sood, MD
Virginia Commonwealth University Health Systems

Elizabeth B. Weller, MD
Children’s Hospital of Philadelphia, University of Pennsylvania

Ronald Weller, MD
University of Pennsylvania

References

  1. Rao U, Ryan ND, Birmaher B, et al. Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry 1995;34:562–78.
  2. Geller B, Fox LW, Clark KA. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year old depressed children. J Am Acad Child Adolesc Psychiatry 1994;33:461–8.
  3. Strober M, Carlson G. Bipolar illness in adolescents with major depression. Arch Gen Psychiatry 1982;39:549–55.

Recommended Reading

Treatment-resistant depression: Is there any other kind?
MDedge Psychiatry
Christmas depression: The data may surprise you
MDedge Psychiatry
Omega-3 fatty acids: Do ‘fish oils’ have a therapeutic role in psychiatry?
MDedge Psychiatry
Psychotic depression: State-of-the-art algorithm improves odds for remission
MDedge Psychiatry
Revised ‘SAD PERSONS’ helps assess suicide risk
MDedge Psychiatry
Treatment-resistant depression: Switch or augment? Choices that improve response rates
MDedge Psychiatry
SSRIs in children and adolescents: Where do we stand?
MDedge Psychiatry
Brain/body connection: Treating depression in patients with cardiovascular disease
MDedge Psychiatry
The painful truth about depression
MDedge Psychiatry
Olanzapine/fluoxetine combination: Evidence for using the first treatment indicated for bipolar depression
MDedge Psychiatry